ASSOCIATED CLINICAL LABORATORIES, LP has sponsored the creation of one or more 401k plans.
Submission information for form 5500 for 401k plan ASSOCIATED CLINICAL LABORATORIES RETIREMENT SAVINGS PLAN
| Measure | Date | Value |
|---|
| 2024 : ASSOCIATED CLINICAL LABORATORIES RETIREMENT SAVINGS PLAN 2024 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2024-01-01 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2024-01-01 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2024-01-01 | $0 |
| Total income from all sources (including contributions) | 2024-01-01 | $1,011,834 |
| Total loss/gain on sale of assets | 2024-01-01 | $0 |
| Total of all expenses incurred | 2024-01-01 | $26,892,557 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2024-01-01 | $26,853,154 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2024-01-01 | $39,601 |
| Value of total assets at end of year | 2024-01-01 | $0 |
| Value of total assets at beginning of year | 2024-01-01 | $25,880,723 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2024-01-01 | $39,403 |
| Total interest from all sources | 2024-01-01 | $23,868 |
| Total dividends received (eg from common stock, registered investment company shares) | 2024-01-01 | $17,525 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2024-01-01 | Yes |
| Value of any plan assets that reverted to the employer resulting from resoluton to terminate the plan | 2024-01-01 | $0 |
| Total dividends received from registered investment company shares (eg mutual funds) | 2024-01-01 | $17,525 |
| Was this plan covered by a fidelity bond | 2024-01-01 | Yes |
| Value of fidelity bond cover | 2024-01-01 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2024-01-01 | Yes |
| Were there any nonexempt tranactions with any party-in-interest | 2024-01-01 | No |
| Contributions received from participants | 2024-01-01 | $25,029 |
| Participant contributions at end of year | 2024-01-01 | $0 |
| Participant contributions at beginning of year | 2024-01-01 | $319,363 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2024-01-01 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2024-01-01 | $0 |
| Total non interest bearing cash at end of year | 2024-01-01 | $0 |
| Total non interest bearing cash at beginning of year | 2024-01-01 | $73 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2024-01-01 | No |
| Value of net income/loss | 2024-01-01 | $-25,880,723 |
| Value of net assets at end of year (total assets less liabilities) | 2024-01-01 | $0 |
| Value of net assets at beginning of year (total assets less liabilities) | 2024-01-01 | $25,880,723 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2024-01-01 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2024-01-01 | No |
| Were any leases to which the plan was party in default or uncollectible | 2024-01-01 | No |
| Investment advisory and management fees | 2024-01-01 | $15,281 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2024-01-01 | $0 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2024-01-01 | $21,446,669 |
| Interest on participant loans | 2024-01-01 | $783 |
| Interest earned on other investments | 2024-01-01 | $23,085 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2024-01-01 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2024-01-01 | $4,114,618 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2024-01-01 | $930,840 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2024-01-01 | No |
| Was there a failure to transmit to the plan any participant contributions | 2024-01-01 | No |
| Has the plan failed to provide any benefit when due under the plan | 2024-01-01 | No |
| Contributions received in cash from employer | 2024-01-01 | $14,572 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2024-01-01 | $26,853,154 |
| Contract administrator fees | 2024-01-01 | $24,122 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2024-01-01 | Yes |
| Did the plan have assets held for investment | 2024-01-01 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2024-01-01 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2024-01-01 | Yes |
| Opinion of an independent qualified public accountant for this plan | 2024-01-01 | 1 |
| Accountancy firm name | 2024-01-01 | RSM US LP |
| Accountancy firm EIN | 2024-01-01 | 420714325 |
| 2023 : ASSOCIATED CLINICAL LABORATORIES RETIREMENT SAVINGS PLAN 2023 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2023-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-12-31 | $0 |
| Total income from all sources (including contributions) | 2023-12-31 | $4,298,288 |
| Total loss/gain on sale of assets | 2023-12-31 | $0 |
| Total of all expenses incurred | 2023-12-31 | $2,473,747 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2023-12-31 | $2,408,203 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2023-12-31 | $1,182,541 |
| Value of total assets at end of year | 2023-12-31 | $25,880,723 |
| Value of total assets at beginning of year | 2023-12-31 | $24,056,182 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2023-12-31 | $65,544 |
| Total interest from all sources | 2023-12-31 | $127,633 |
| Total dividends received (eg from common stock, registered investment company shares) | 2023-12-31 | $556,961 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2023-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2023-12-31 | $556,961 |
| Was this plan covered by a fidelity bond | 2023-12-31 | Yes |
| Value of fidelity bond cover | 2023-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2023-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2023-12-31 | No |
| Contributions received from participants | 2023-12-31 | $758,115 |
| Participant contributions at end of year | 2023-12-31 | $319,363 |
| Participant contributions at beginning of year | 2023-12-31 | $285,752 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2023-12-31 | $0 |
| Total non interest bearing cash at end of year | 2023-12-31 | $73 |
| Total non interest bearing cash at beginning of year | 2023-12-31 | $53 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-12-31 | No |
| Value of net income/loss | 2023-12-31 | $1,824,541 |
| Value of net assets at end of year (total assets less liabilities) | 2023-12-31 | $25,880,723 |
| Value of net assets at beginning of year (total assets less liabilities) | 2023-12-31 | $24,056,182 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2023-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2023-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2023-12-31 | No |
| Investment advisory and management fees | 2023-12-31 | $24,381 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2023-12-31 | $21,446,669 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2023-12-31 | $19,657,653 |
| Interest on participant loans | 2023-12-31 | $15,618 |
| Interest earned on other investments | 2023-12-31 | $112,015 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2023-12-31 | $4,114,618 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2023-12-31 | $4,112,724 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2023-12-31 | $2,431,153 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2023-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2023-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2023-12-31 | No |
| Contributions received in cash from employer | 2023-12-31 | $424,426 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2023-12-31 | $2,408,203 |
| Contract administrator fees | 2023-12-31 | $41,163 |
| Did the plan have assets held for investment | 2023-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2023-12-31 | No |
| Opinion of an independent qualified public accountant for this plan | 2023-12-31 | Unqualified |
| Accountancy firm name | 2023-12-31 | RSM US LP |
| Accountancy firm EIN | 2023-12-31 | 420714325 |
| Total unrealized appreciation/depreciation of assets | 2023-01-01 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-01-01 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-01-01 | $0 |
| Total income from all sources (including contributions) | 2023-01-01 | $4,298,288 |
| Total loss/gain on sale of assets | 2023-01-01 | $0 |
| Total of all expenses incurred | 2023-01-01 | $2,473,747 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2023-01-01 | $2,408,203 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2023-01-01 | $1,182,541 |
| Value of total assets at end of year | 2023-01-01 | $25,880,723 |
| Value of total assets at beginning of year | 2023-01-01 | $24,056,182 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2023-01-01 | $65,544 |
| Total interest from all sources | 2023-01-01 | $127,633 |
| Total dividends received (eg from common stock, registered investment company shares) | 2023-01-01 | $556,961 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2023-01-01 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2023-01-01 | $556,961 |
| Was this plan covered by a fidelity bond | 2023-01-01 | Yes |
| Value of fidelity bond cover | 2023-01-01 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2023-01-01 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2023-01-01 | No |
| Contributions received from participants | 2023-01-01 | $758,115 |
| Participant contributions at end of year | 2023-01-01 | $319,363 |
| Participant contributions at beginning of year | 2023-01-01 | $285,752 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2023-01-01 | $0 |
| Total non interest bearing cash at end of year | 2023-01-01 | $73 |
| Total non interest bearing cash at beginning of year | 2023-01-01 | $53 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-01-01 | No |
| Value of net income/loss | 2023-01-01 | $1,824,541 |
| Value of net assets at end of year (total assets less liabilities) | 2023-01-01 | $25,880,723 |
| Value of net assets at beginning of year (total assets less liabilities) | 2023-01-01 | $24,056,182 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2023-01-01 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2023-01-01 | No |
| Were any leases to which the plan was party in default or uncollectible | 2023-01-01 | No |
| Investment advisory and management fees | 2023-01-01 | $24,381 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2023-01-01 | $21,446,669 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2023-01-01 | $19,657,653 |
| Interest on participant loans | 2023-01-01 | $15,618 |
| Interest earned on other investments | 2023-01-01 | $112,015 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2023-01-01 | $4,114,618 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2023-01-01 | $4,112,724 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2023-01-01 | $2,431,153 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2023-01-01 | No |
| Was there a failure to transmit to the plan any participant contributions | 2023-01-01 | No |
| Has the plan failed to provide any benefit when due under the plan | 2023-01-01 | No |
| Contributions received in cash from employer | 2023-01-01 | $424,426 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2023-01-01 | $2,408,203 |
| Contract administrator fees | 2023-01-01 | $41,163 |
| Did the plan have assets held for investment | 2023-01-01 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-01-01 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2023-01-01 | No |
| Opinion of an independent qualified public accountant for this plan | 2023-01-01 | 1 |
| Accountancy firm name | 2023-01-01 | RSM US LP |
| Accountancy firm EIN | 2023-01-01 | 420714325 |
| 2022 : ASSOCIATED CLINICAL LABORATORIES RETIREMENT SAVINGS PLAN 2022 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2022-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
| Total income from all sources (including contributions) | 2022-12-31 | $-2,915,360 |
| Total loss/gain on sale of assets | 2022-12-31 | $0 |
| Total of all expenses incurred | 2022-12-31 | $4,851,111 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-12-31 | $4,782,019 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-12-31 | $1,043,551 |
| Value of total assets at end of year | 2022-12-31 | $24,056,182 |
| Value of total assets at beginning of year | 2022-12-31 | $31,822,653 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-12-31 | $69,092 |
| Total interest from all sources | 2022-12-31 | $103,627 |
| Total dividends received (eg from common stock, registered investment company shares) | 2022-12-31 | $508,027 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2022-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2022-12-31 | $508,027 |
| Was this plan covered by a fidelity bond | 2022-12-31 | Yes |
| Value of fidelity bond cover | 2022-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2022-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2022-12-31 | No |
| Contributions received from participants | 2022-12-31 | $649,758 |
| Participant contributions at end of year | 2022-12-31 | $285,752 |
| Participant contributions at beginning of year | 2022-12-31 | $268,481 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2022-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2022-12-31 | $350,164 |
| Total non interest bearing cash at end of year | 2022-12-31 | $53 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
| Value of net income/loss | 2022-12-31 | $-7,766,471 |
| Value of net assets at end of year (total assets less liabilities) | 2022-12-31 | $24,056,182 |
| Value of net assets at beginning of year (total assets less liabilities) | 2022-12-31 | $31,822,653 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2022-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2022-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2022-12-31 | No |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2022-12-31 | $19,657,653 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-12-31 | $26,783,139 |
| Interest on participant loans | 2022-12-31 | $11,772 |
| Interest earned on other investments | 2022-12-31 | $91,855 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2022-12-31 | $4,112,724 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2022-12-31 | $4,420,869 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2022-12-31 | $-4,570,565 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2022-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2022-12-31 | No |
| Contributions received in cash from employer | 2022-12-31 | $393,793 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2022-12-31 | $4,782,019 |
| Contract administrator fees | 2022-12-31 | $69,092 |
| Did the plan have assets held for investment | 2022-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2022-12-31 | No |
| Opinion of an independent qualified public accountant for this plan | 2022-12-31 | Unqualified |
| Accountancy firm name | 2022-12-31 | RSM US LP |
| Accountancy firm EIN | 2022-12-31 | 420714325 |
| Total unrealized appreciation/depreciation of assets | 2022-01-01 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-01-01 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-01-01 | $0 |
| Total income from all sources (including contributions) | 2022-01-01 | $-2,915,360 |
| Total loss/gain on sale of assets | 2022-01-01 | $0 |
| Total of all expenses incurred | 2022-01-01 | $4,851,111 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-01-01 | $4,782,019 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-01-01 | $1,043,551 |
| Value of total assets at end of year | 2022-01-01 | $24,056,182 |
| Value of total assets at beginning of year | 2022-01-01 | $31,822,653 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-01-01 | $69,092 |
| Total interest from all sources | 2022-01-01 | $103,627 |
| Total dividends received (eg from common stock, registered investment company shares) | 2022-01-01 | $508,027 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2022-01-01 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2022-01-01 | $508,027 |
| Was this plan covered by a fidelity bond | 2022-01-01 | Yes |
| Value of fidelity bond cover | 2022-01-01 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2022-01-01 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2022-01-01 | No |
| Contributions received from participants | 2022-01-01 | $649,758 |
| Participant contributions at end of year | 2022-01-01 | $285,752 |
| Participant contributions at beginning of year | 2022-01-01 | $268,481 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2022-01-01 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2022-01-01 | $350,164 |
| Total non interest bearing cash at end of year | 2022-01-01 | $53 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-01-01 | No |
| Value of net income/loss | 2022-01-01 | $-7,766,471 |
| Value of net assets at end of year (total assets less liabilities) | 2022-01-01 | $24,056,182 |
| Value of net assets at beginning of year (total assets less liabilities) | 2022-01-01 | $31,822,653 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2022-01-01 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2022-01-01 | No |
| Were any leases to which the plan was party in default or uncollectible | 2022-01-01 | No |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2022-01-01 | $19,657,653 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-01-01 | $26,783,139 |
| Interest on participant loans | 2022-01-01 | $11,772 |
| Interest earned on other investments | 2022-01-01 | $91,855 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2022-01-01 | $4,112,724 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2022-01-01 | $4,420,869 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2022-01-01 | $-4,570,565 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-01-01 | No |
| Was there a failure to transmit to the plan any participant contributions | 2022-01-01 | No |
| Has the plan failed to provide any benefit when due under the plan | 2022-01-01 | No |
| Contributions received in cash from employer | 2022-01-01 | $393,793 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2022-01-01 | $4,782,019 |
| Contract administrator fees | 2022-01-01 | $69,092 |
| Did the plan have assets held for investment | 2022-01-01 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-01-01 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2022-01-01 | No |
| Opinion of an independent qualified public accountant for this plan | 2022-01-01 | 1 |
| Accountancy firm name | 2022-01-01 | RSM US LP |
| Accountancy firm EIN | 2022-01-01 | 420714325 |
| 2021 : ASSOCIATED CLINICAL LABORATORIES RETIREMENT SAVINGS PLAN 2021 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2021-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
| Total income from all sources (including contributions) | 2021-12-31 | $5,817,823 |
| Total loss/gain on sale of assets | 2021-12-31 | $0 |
| Total of all expenses incurred | 2021-12-31 | $5,559,729 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2021-12-31 | $5,459,172 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2021-12-31 | $1,177,560 |
| Value of total assets at end of year | 2021-12-31 | $31,822,653 |
| Value of total assets at beginning of year | 2021-12-31 | $31,564,559 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2021-12-31 | $100,557 |
| Total interest from all sources | 2021-12-31 | $15,198 |
| Total dividends received (eg from common stock, registered investment company shares) | 2021-12-31 | $1,930,401 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2021-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2021-12-31 | $1,930,401 |
| Was this plan covered by a fidelity bond | 2021-12-31 | Yes |
| Value of fidelity bond cover | 2021-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2021-12-31 | Yes |
| Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2021-12-31 | $0 |
| Were there any nonexempt tranactions with any party-in-interest | 2021-12-31 | No |
| Contributions received from participants | 2021-12-31 | $730,551 |
| Participant contributions at end of year | 2021-12-31 | $268,481 |
| Participant contributions at beginning of year | 2021-12-31 | $367,305 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2021-12-31 | $40,073 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2021-12-31 | $350,164 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
| Value of net income/loss | 2021-12-31 | $258,094 |
| Value of net assets at end of year (total assets less liabilities) | 2021-12-31 | $31,822,653 |
| Value of net assets at beginning of year (total assets less liabilities) | 2021-12-31 | $31,564,559 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2021-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2021-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2021-12-31 | No |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2021-12-31 | $26,783,139 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2021-12-31 | $29,597,412 |
| Interest on participant loans | 2021-12-31 | $15,198 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2021-12-31 | $4,420,869 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2021-12-31 | $1,599,842 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2021-12-31 | $2,694,664 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2021-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2021-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2021-12-31 | No |
| Contributions received in cash from employer | 2021-12-31 | $406,936 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2021-12-31 | $5,459,172 |
| Contract administrator fees | 2021-12-31 | $100,557 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2021-12-31 | Yes |
| Did the plan have assets held for investment | 2021-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2021-12-31 | No |
| Opinion of an independent qualified public accountant for this plan | 2021-12-31 | Unqualified |
| Accountancy firm name | 2021-12-31 | RSM US LP |
| Accountancy firm EIN | 2021-12-31 | 420714325 |
| 2020 : ASSOCIATED CLINICAL LABORATORIES RETIREMENT SAVINGS PLAN 2020 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2020-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
| Total income from all sources (including contributions) | 2020-12-31 | $4,623,299 |
| Total loss/gain on sale of assets | 2020-12-31 | $0 |
| Total of all expenses incurred | 2020-12-31 | $4,823,284 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2020-12-31 | $4,792,238 |
| Expenses. Certain deemed distributions of participant loans | 2020-12-31 | $0 |
| Value of total corrective distributions | 2020-12-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2020-12-31 | $1,059,214 |
| Value of total assets at end of year | 2020-12-31 | $31,564,559 |
| Value of total assets at beginning of year | 2020-12-31 | $31,764,544 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2020-12-31 | $31,046 |
| Total interest from all sources | 2020-12-31 | $359,426 |
| Total dividends received (eg from common stock, registered investment company shares) | 2020-12-31 | $619,891 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2020-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2020-12-31 | $619,891 |
| Administrative expenses professional fees incurred | 2020-12-31 | $8,900 |
| Was this plan covered by a fidelity bond | 2020-12-31 | Yes |
| Value of fidelity bond cover | 2020-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2020-12-31 | No |
| Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2020-12-31 | $0 |
| Were there any nonexempt tranactions with any party-in-interest | 2020-12-31 | No |
| Contributions received from participants | 2020-12-31 | $711,148 |
| Participant contributions at end of year | 2020-12-31 | $367,305 |
| Participant contributions at beginning of year | 2020-12-31 | $435,960 |
| Assets. Other investments not covered elsewhere at end of year | 2020-12-31 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2020-12-31 | $0 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2020-12-31 | $32,736 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2020-12-31 | $0 |
| Other income not declared elsewhere | 2020-12-31 | $0 |
| Administrative expenses (other) incurred | 2020-12-31 | $0 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
| Value of net income/loss | 2020-12-31 | $-199,985 |
| Value of net assets at end of year (total assets less liabilities) | 2020-12-31 | $31,564,559 |
| Value of net assets at beginning of year (total assets less liabilities) | 2020-12-31 | $31,764,544 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2020-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2020-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2020-12-31 | No |
| Investment advisory and management fees | 2020-12-31 | $16,826 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2020-12-31 | $29,597,412 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2020-12-31 | $25,875,000 |
| Value of interest in pooled separate accounts at end of year | 2020-12-31 | $0 |
| Value of interest in pooled separate accounts at beginning of year | 2020-12-31 | $0 |
| Interest on participant loans | 2020-12-31 | $20,615 |
| Interest earned on other investments | 2020-12-31 | $338,811 |
| Value of interest in common/collective trusts at end of year | 2020-12-31 | $0 |
| Value of interest in common/collective trusts at beginning of year | 2020-12-31 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2020-12-31 | $1,599,842 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2020-12-31 | $5,453,584 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2020-12-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2020-12-31 | $2,584,768 |
| Net investment gain/loss from pooled separate accounts | 2020-12-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2020-12-31 | $0 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2020-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2020-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2020-12-31 | No |
| Assets. Invements in employer securities at end of year | 2020-12-31 | $0 |
| Assets. Invements in employer securities at beginning of year | 2020-12-31 | $0 |
| Contributions received in cash from employer | 2020-12-31 | $315,330 |
| Income. Dividends from common stock | 2020-12-31 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2020-12-31 | $4,792,238 |
| Contract administrator fees | 2020-12-31 | $5,320 |
| Did the plan have assets held for investment | 2020-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2020-12-31 | No |
| Opinion of an independent qualified public accountant for this plan | 2020-12-31 | Disclaimer |
| Accountancy firm name | 2020-12-31 | RSM US LP |
| Accountancy firm EIN | 2020-12-31 | 420714325 |
| 2019 : ASSOCIATED CLINICAL LABORATORIES RETIREMENT SAVINGS PLAN 2019 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2019-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
| Total income from all sources (including contributions) | 2019-12-31 | $6,837,610 |
| Total loss/gain on sale of assets | 2019-12-31 | $0 |
| Total of all expenses incurred | 2019-12-31 | $2,525,052 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2019-12-31 | $2,507,497 |
| Expenses. Certain deemed distributions of participant loans | 2019-12-31 | $0 |
| Value of total corrective distributions | 2019-12-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2019-12-31 | $1,331,500 |
| Value of total assets at end of year | 2019-12-31 | $31,764,544 |
| Value of total assets at beginning of year | 2019-12-31 | $27,451,986 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2019-12-31 | $17,555 |
| Total interest from all sources | 2019-12-31 | $176,009 |
| Total dividends received (eg from common stock, registered investment company shares) | 2019-12-31 | $1,231,669 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2019-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2019-12-31 | $1,231,669 |
| Administrative expenses professional fees incurred | 2019-12-31 | $7,700 |
| Was this plan covered by a fidelity bond | 2019-12-31 | Yes |
| Value of fidelity bond cover | 2019-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2019-12-31 | No |
| Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2019-12-31 | $0 |
| Were there any nonexempt tranactions with any party-in-interest | 2019-12-31 | No |
| Contributions received from participants | 2019-12-31 | $730,920 |
| Participant contributions at end of year | 2019-12-31 | $435,960 |
| Participant contributions at beginning of year | 2019-12-31 | $555,029 |
| Participant contributions at beginning of year | 2019-12-31 | $27,420 |
| Assets. Other investments not covered elsewhere at end of year | 2019-12-31 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2019-12-31 | $0 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2019-12-31 | $162,246 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2019-12-31 | $0 |
| Other income not declared elsewhere | 2019-12-31 | $0 |
| Administrative expenses (other) incurred | 2019-12-31 | $880 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
| Value of net income/loss | 2019-12-31 | $4,312,558 |
| Value of net assets at end of year (total assets less liabilities) | 2019-12-31 | $31,764,544 |
| Value of net assets at beginning of year (total assets less liabilities) | 2019-12-31 | $27,451,986 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2019-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2019-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2019-12-31 | No |
| Investment advisory and management fees | 2019-12-31 | $0 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2019-12-31 | $25,875,000 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2019-12-31 | $21,629,506 |
| Value of interest in pooled separate accounts at end of year | 2019-12-31 | $0 |
| Value of interest in pooled separate accounts at beginning of year | 2019-12-31 | $0 |
| Interest on participant loans | 2019-12-31 | $27,673 |
| Interest earned on other investments | 2019-12-31 | $148,336 |
| Value of interest in common/collective trusts at end of year | 2019-12-31 | $0 |
| Value of interest in common/collective trusts at beginning of year | 2019-12-31 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2019-12-31 | $5,453,584 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2019-12-31 | $5,224,015 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2019-12-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2019-12-31 | $4,098,432 |
| Net investment gain/loss from pooled separate accounts | 2019-12-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2019-12-31 | $0 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2019-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2019-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2019-12-31 | No |
| Assets. Invements in employer securities at end of year | 2019-12-31 | $0 |
| Assets. Invements in employer securities at beginning of year | 2019-12-31 | $0 |
| Contributions received in cash from employer | 2019-12-31 | $438,334 |
| Employer contributions (assets) at beginning of year | 2019-12-31 | $16,016 |
| Income. Dividends from common stock | 2019-12-31 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2019-12-31 | $2,507,497 |
| Contract administrator fees | 2019-12-31 | $8,975 |
| Did the plan have assets held for investment | 2019-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2019-12-31 | No |
| Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2019-12-31 | Yes |
| Opinion of an independent qualified public accountant for this plan | 2019-12-31 | Disclaimer |
| Accountancy firm name | 2019-12-31 | RSM US LP |
| Accountancy firm EIN | 2019-12-31 | 420714325 |
| 2018 : ASSOCIATED CLINICAL LABORATORIES RETIREMENT SAVINGS PLAN 2018 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2018-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2018-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2018-12-31 | $0 |
| Total income from all sources (including contributions) | 2018-12-31 | $489,232 |
| Total loss/gain on sale of assets | 2018-12-31 | $0 |
| Total of all expenses incurred | 2018-12-31 | $2,052,324 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2018-12-31 | $2,034,682 |
| Expenses. Certain deemed distributions of participant loans | 2018-12-31 | $0 |
| Value of total corrective distributions | 2018-12-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2018-12-31 | $1,294,415 |
| Value of total assets at end of year | 2018-12-31 | $27,451,986 |
| Value of total assets at beginning of year | 2018-12-31 | $29,015,078 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2018-12-31 | $17,642 |
| Total interest from all sources | 2018-12-31 | $175,316 |
| Total dividends received (eg from common stock, registered investment company shares) | 2018-12-31 | $1,222,875 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2018-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2018-12-31 | $1,222,875 |
| Administrative expenses professional fees incurred | 2018-12-31 | $8,983 |
| Was this plan covered by a fidelity bond | 2018-12-31 | Yes |
| Value of fidelity bond cover | 2018-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2018-12-31 | No |
| Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2018-12-31 | $0 |
| Were there any nonexempt tranactions with any party-in-interest | 2018-12-31 | No |
| Contributions received from participants | 2018-12-31 | $809,593 |
| Participant contributions at end of year | 2018-12-31 | $555,029 |
| Participant contributions at beginning of year | 2018-12-31 | $646,753 |
| Participant contributions at end of year | 2018-12-31 | $27,420 |
| Participant contributions at beginning of year | 2018-12-31 | $29,308 |
| Assets. Other investments not covered elsewhere at end of year | 2018-12-31 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2018-12-31 | $0 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2018-12-31 | $24,709 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2018-12-31 | $0 |
| Other income not declared elsewhere | 2018-12-31 | $0 |
| Administrative expenses (other) incurred | 2018-12-31 | $1,068 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2018-12-31 | No |
| Value of net income/loss | 2018-12-31 | $-1,563,092 |
| Value of net assets at end of year (total assets less liabilities) | 2018-12-31 | $27,451,986 |
| Value of net assets at beginning of year (total assets less liabilities) | 2018-12-31 | $29,015,078 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2018-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2018-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2018-12-31 | No |
| Investment advisory and management fees | 2018-12-31 | $0 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2018-12-31 | $21,629,506 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2018-12-31 | $23,510,459 |
| Value of interest in pooled separate accounts at end of year | 2018-12-31 | $0 |
| Value of interest in pooled separate accounts at beginning of year | 2018-12-31 | $0 |
| Interest on participant loans | 2018-12-31 | $30,798 |
| Interest earned on other investments | 2018-12-31 | $144,518 |
| Value of interest in common/collective trusts at end of year | 2018-12-31 | $0 |
| Value of interest in common/collective trusts at beginning of year | 2018-12-31 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2018-12-31 | $5,224,015 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2018-12-31 | $4,811,705 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2018-12-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2018-12-31 | $-2,203,374 |
| Net investment gain/loss from pooled separate accounts | 2018-12-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2018-12-31 | $0 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2018-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2018-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2018-12-31 | No |
| Assets. Invements in employer securities at end of year | 2018-12-31 | $0 |
| Assets. Invements in employer securities at beginning of year | 2018-12-31 | $0 |
| Contributions received in cash from employer | 2018-12-31 | $460,113 |
| Employer contributions (assets) at end of year | 2018-12-31 | $16,016 |
| Employer contributions (assets) at beginning of year | 2018-12-31 | $16,853 |
| Income. Dividends from common stock | 2018-12-31 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2018-12-31 | $2,034,682 |
| Contract administrator fees | 2018-12-31 | $7,591 |
| Did the plan have assets held for investment | 2018-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2018-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2018-12-31 | No |
| Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2018-12-31 | Yes |
| Opinion of an independent qualified public accountant for this plan | 2018-12-31 | Disclaimer |
| Accountancy firm name | 2018-12-31 | RSM US LLC |
| Accountancy firm EIN | 2018-12-31 | 420714325 |
| 2017 : ASSOCIATED CLINICAL LABORATORIES RETIREMENT SAVINGS PLAN 2017 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2017-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2017-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2017-12-31 | $0 |
| Total income from all sources (including contributions) | 2017-12-31 | $5,119,298 |
| Total loss/gain on sale of assets | 2017-12-31 | $0 |
| Total of all expenses incurred | 2017-12-31 | $3,861,319 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2017-12-31 | $3,833,719 |
| Expenses. Certain deemed distributions of participant loans | 2017-12-31 | $0 |
| Value of total corrective distributions | 2017-12-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2017-12-31 | $1,355,033 |
| Value of total assets at end of year | 2017-12-31 | $29,015,078 |
| Value of total assets at beginning of year | 2017-12-31 | $27,757,099 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2017-12-31 | $27,600 |
| Total interest from all sources | 2017-12-31 | $158,618 |
| Total dividends received (eg from common stock, registered investment company shares) | 2017-12-31 | $924,138 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2017-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2017-12-31 | $924,138 |
| Administrative expenses professional fees incurred | 2017-12-31 | $16,393 |
| Was this plan covered by a fidelity bond | 2017-12-31 | Yes |
| Value of fidelity bond cover | 2017-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2017-12-31 | No |
| Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2017-12-31 | $0 |
| Were there any nonexempt tranactions with any party-in-interest | 2017-12-31 | No |
| Contributions received from participants | 2017-12-31 | $782,352 |
| Participant contributions at end of year | 2017-12-31 | $646,753 |
| Participant contributions at beginning of year | 2017-12-31 | $653,747 |
| Participant contributions at end of year | 2017-12-31 | $29,308 |
| Participant contributions at beginning of year | 2017-12-31 | $27,405 |
| Assets. Other investments not covered elsewhere at end of year | 2017-12-31 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2017-12-31 | $0 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2017-12-31 | $119,695 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2017-12-31 | $0 |
| Other income not declared elsewhere | 2017-12-31 | $0 |
| Administrative expenses (other) incurred | 2017-12-31 | $7 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2017-12-31 | No |
| Value of net income/loss | 2017-12-31 | $1,257,979 |
| Value of net assets at end of year (total assets less liabilities) | 2017-12-31 | $29,015,078 |
| Value of net assets at beginning of year (total assets less liabilities) | 2017-12-31 | $27,757,099 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2017-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2017-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2017-12-31 | No |
| Investment advisory and management fees | 2017-12-31 | $0 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2017-12-31 | $23,510,459 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2017-12-31 | $21,272,575 |
| Value of interest in pooled separate accounts at end of year | 2017-12-31 | $0 |
| Value of interest in pooled separate accounts at beginning of year | 2017-12-31 | $0 |
| Interest on participant loans | 2017-12-31 | $30,582 |
| Interest earned on other investments | 2017-12-31 | $128,036 |
| Value of interest in common/collective trusts at end of year | 2017-12-31 | $0 |
| Value of interest in common/collective trusts at beginning of year | 2017-12-31 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2017-12-31 | $4,811,705 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2017-12-31 | $5,787,387 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2017-12-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2017-12-31 | $2,681,509 |
| Net investment gain/loss from pooled separate accounts | 2017-12-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2017-12-31 | $0 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2017-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2017-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2017-12-31 | No |
| Assets. Invements in employer securities at end of year | 2017-12-31 | $0 |
| Assets. Invements in employer securities at beginning of year | 2017-12-31 | $0 |
| Contributions received in cash from employer | 2017-12-31 | $452,986 |
| Employer contributions (assets) at end of year | 2017-12-31 | $16,853 |
| Employer contributions (assets) at beginning of year | 2017-12-31 | $15,985 |
| Income. Dividends from common stock | 2017-12-31 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2017-12-31 | $3,833,719 |
| Contract administrator fees | 2017-12-31 | $11,200 |
| Did the plan have assets held for investment | 2017-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2017-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2017-12-31 | No |
| Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2017-12-31 | Yes |
| Opinion of an independent qualified public accountant for this plan | 2017-12-31 | Disclaimer |
| Accountancy firm name | 2017-12-31 | RSM US LLP |
| Accountancy firm EIN | 2017-12-31 | 420714325 |
| 2016 : ASSOCIATED CLINICAL LABORATORIES RETIREMENT SAVINGS PLAN 2016 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2016-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2016-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2016-12-31 | $0 |
| Total income from all sources (including contributions) | 2016-12-31 | $2,914,721 |
| Total loss/gain on sale of assets | 2016-12-31 | $-747 |
| Total of all expenses incurred | 2016-12-31 | $2,154,089 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2016-12-31 | $2,052,913 |
| Expenses. Certain deemed distributions of participant loans | 2016-12-31 | $0 |
| Value of total corrective distributions | 2016-12-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2016-12-31 | $1,180,482 |
| Value of total assets at end of year | 2016-12-31 | $27,757,099 |
| Value of total assets at beginning of year | 2016-12-31 | $26,996,467 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2016-12-31 | $101,176 |
| Total interest from all sources | 2016-12-31 | $78,497 |
| Total dividends received (eg from common stock, registered investment company shares) | 2016-12-31 | $681,645 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2016-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2016-12-31 | $681,645 |
| Administrative expenses professional fees incurred | 2016-12-31 | $97,035 |
| Was this plan covered by a fidelity bond | 2016-12-31 | Yes |
| Value of fidelity bond cover | 2016-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2016-12-31 | No |
| Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2016-12-31 | $0 |
| Were there any nonexempt tranactions with any party-in-interest | 2016-12-31 | No |
| Contributions received from participants | 2016-12-31 | $743,450 |
| Participant contributions at end of year | 2016-12-31 | $653,747 |
| Participant contributions at beginning of year | 2016-12-31 | $603,041 |
| Participant contributions at end of year | 2016-12-31 | $27,405 |
| Participant contributions at beginning of year | 2016-12-31 | $25,455 |
| Assets. Other investments not covered elsewhere at end of year | 2016-12-31 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2016-12-31 | $0 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2016-12-31 | $8,979 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2016-12-31 | $0 |
| Other income not declared elsewhere | 2016-12-31 | $83,426 |
| Administrative expenses (other) incurred | 2016-12-31 | $66 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2016-12-31 | No |
| Value of net income/loss | 2016-12-31 | $760,632 |
| Value of net assets at end of year (total assets less liabilities) | 2016-12-31 | $27,757,099 |
| Value of net assets at beginning of year (total assets less liabilities) | 2016-12-31 | $26,996,467 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2016-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2016-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2016-12-31 | No |
| Investment advisory and management fees | 2016-12-31 | $0 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2016-12-31 | $21,272,575 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2016-12-31 | $20,341,681 |
| Value of interest in pooled separate accounts at end of year | 2016-12-31 | $0 |
| Value of interest in pooled separate accounts at beginning of year | 2016-12-31 | $0 |
| Interest on participant loans | 2016-12-31 | $27,358 |
| Interest earned on other investments | 2016-12-31 | $51,139 |
| Value of interest in common/collective trusts at end of year | 2016-12-31 | $0 |
| Value of interest in common/collective trusts at beginning of year | 2016-12-31 | $6,010,546 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2016-12-31 | $5,787,387 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2016-12-31 | $0 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2016-12-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2016-12-31 | $862,714 |
| Net investment gain/loss from pooled separate accounts | 2016-12-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2016-12-31 | $28,704 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2016-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2016-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2016-12-31 | No |
| Assets. Invements in employer securities at end of year | 2016-12-31 | $0 |
| Assets. Invements in employer securities at beginning of year | 2016-12-31 | $0 |
| Contributions received in cash from employer | 2016-12-31 | $428,053 |
| Employer contributions (assets) at end of year | 2016-12-31 | $15,985 |
| Employer contributions (assets) at beginning of year | 2016-12-31 | $15,744 |
| Income. Dividends from common stock | 2016-12-31 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2016-12-31 | $2,052,913 |
| Contract administrator fees | 2016-12-31 | $4,075 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2016-12-31 | No |
| Did the plan have assets held for investment | 2016-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2016-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2016-12-31 | No |
| Aggregate proceeds on sale of assets | 2016-12-31 | $3,644,933 |
| Aggregate carrying amount (costs) on sale of assets | 2016-12-31 | $3,645,680 |
| Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2016-12-31 | Yes |
| Opinion of an independent qualified public accountant for this plan | 2016-12-31 | Disclaimer |
| Accountancy firm name | 2016-12-31 | RSM US LLP |
| Accountancy firm EIN | 2016-12-31 | 420714325 |
| 2015 : ASSOCIATED CLINICAL LABORATORIES RETIREMENT SAVINGS PLAN 2015 401k financial data |
|---|
| Total income from all sources (including contributions) | 2015-12-31 | $1,661,966 |
| Total loss/gain on sale of assets | 2015-12-31 | $11,564 |
| Total of all expenses incurred | 2015-12-31 | $1,778,935 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2015-12-31 | $1,703,345 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2015-12-31 | $1,194,941 |
| Value of total assets at end of year | 2015-12-31 | $26,996,467 |
| Value of total assets at beginning of year | 2015-12-31 | $27,113,436 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2015-12-31 | $75,590 |
| Total interest from all sources | 2015-12-31 | $25,754 |
| Total dividends received (eg from common stock, registered investment company shares) | 2015-12-31 | $1,451,848 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2015-12-31 | No |
| Administrative expenses professional fees incurred | 2015-12-31 | $75,590 |
| Was this plan covered by a fidelity bond | 2015-12-31 | Yes |
| Value of fidelity bond cover | 2015-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2015-12-31 | No |
| Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2015-12-31 | $0 |
| Were there any nonexempt tranactions with any party-in-interest | 2015-12-31 | No |
| Contributions received from participants | 2015-12-31 | $719,230 |
| Participant contributions at end of year | 2015-12-31 | $603,041 |
| Participant contributions at beginning of year | 2015-12-31 | $603,079 |
| Participant contributions at end of year | 2015-12-31 | $25,455 |
| Participant contributions at beginning of year | 2015-12-31 | $25,538 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2015-12-31 | $34,943 |
| Other income not declared elsewhere | 2015-12-31 | $110,301 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2015-12-31 | No |
| Value of net income/loss | 2015-12-31 | $-116,969 |
| Value of net assets at end of year (total assets less liabilities) | 2015-12-31 | $26,996,467 |
| Value of net assets at beginning of year (total assets less liabilities) | 2015-12-31 | $27,113,436 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2015-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2015-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2015-12-31 | No |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2015-12-31 | $20,341,681 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2015-12-31 | $20,538,494 |
| Interest on participant loans | 2015-12-31 | $25,754 |
| Value of interest in common/collective trusts at end of year | 2015-12-31 | $6,010,546 |
| Value of interest in common/collective trusts at beginning of year | 2015-12-31 | $5,930,122 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2015-12-31 | $-1,178,365 |
| Net investment gain or loss from common/collective trusts | 2015-12-31 | $45,923 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2015-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2015-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2015-12-31 | No |
| Contributions received in cash from employer | 2015-12-31 | $440,768 |
| Employer contributions (assets) at end of year | 2015-12-31 | $15,744 |
| Employer contributions (assets) at beginning of year | 2015-12-31 | $16,203 |
| Income. Dividends from common stock | 2015-12-31 | $1,451,848 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2015-12-31 | $1,703,345 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2015-12-31 | No |
| Did the plan have assets held for investment | 2015-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2015-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2015-12-31 | No |
| Aggregate proceeds on sale of assets | 2015-12-31 | $3,289,424 |
| Aggregate carrying amount (costs) on sale of assets | 2015-12-31 | $3,277,860 |
| Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2015-12-31 | Yes |
| Opinion of an independent qualified public accountant for this plan | 2015-12-31 | Disclaimer |
| Accountancy firm name | 2015-12-31 | RSM US LLP |
| Accountancy firm EIN | 2015-12-31 | 420714325 |
| 2014 : ASSOCIATED CLINICAL LABORATORIES RETIREMENT SAVINGS PLAN 2014 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2014-12-31 | $-13 |
| Total unrealized appreciation/depreciation of assets | 2014-12-31 | $-13 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2014-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2014-12-31 | $0 |
| Total income from all sources (including contributions) | 2014-12-31 | $2,905,828 |
| Total loss/gain on sale of assets | 2014-12-31 | $62,967 |
| Total of all expenses incurred | 2014-12-31 | $3,154,130 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2014-12-31 | $3,154,130 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2014-12-31 | $1,157,755 |
| Value of total assets at end of year | 2014-12-31 | $27,113,436 |
| Value of total assets at beginning of year | 2014-12-31 | $27,361,738 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2014-12-31 | $0 |
| Total interest from all sources | 2014-12-31 | $24,703 |
| Total dividends received (eg from common stock, registered investment company shares) | 2014-12-31 | $1,361,316 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2014-12-31 | No |
| Was this plan covered by a fidelity bond | 2014-12-31 | Yes |
| Value of fidelity bond cover | 2014-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2014-12-31 | No |
| Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2014-12-31 | $0 |
| Were there any nonexempt tranactions with any party-in-interest | 2014-12-31 | No |
| Contributions received from participants | 2014-12-31 | $708,213 |
| Participant contributions at end of year | 2014-12-31 | $603,079 |
| Participant contributions at beginning of year | 2014-12-31 | $679,434 |
| Participant contributions at end of year | 2014-12-31 | $25,538 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2014-12-31 | $5,957 |
| Other income not declared elsewhere | 2014-12-31 | $27,397 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2014-12-31 | No |
| Value of net income/loss | 2014-12-31 | $-248,302 |
| Value of net assets at end of year (total assets less liabilities) | 2014-12-31 | $27,113,436 |
| Value of net assets at beginning of year (total assets less liabilities) | 2014-12-31 | $27,361,738 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2014-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2014-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2014-12-31 | No |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2014-12-31 | $20,538,494 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2014-12-31 | $20,086,675 |
| Interest on participant loans | 2014-12-31 | $24,703 |
| Value of interest in common/collective trusts at end of year | 2014-12-31 | $5,930,122 |
| Value of interest in common/collective trusts at beginning of year | 2014-12-31 | $6,595,629 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2014-12-31 | $232,005 |
| Net investment gain or loss from common/collective trusts | 2014-12-31 | $39,698 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2014-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2014-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2014-12-31 | No |
| Contributions received in cash from employer | 2014-12-31 | $443,585 |
| Employer contributions (assets) at end of year | 2014-12-31 | $16,203 |
| Income. Dividends from common stock | 2014-12-31 | $1,361,316 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2014-12-31 | $3,154,130 |
| Did the plan have assets held for investment | 2014-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2014-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2014-12-31 | No |
| Aggregate proceeds on sale of assets | 2014-12-31 | $6,575,703 |
| Aggregate carrying amount (costs) on sale of assets | 2014-12-31 | $6,512,736 |
| Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2014-12-31 | Yes |
| Opinion of an independent qualified public accountant for this plan | 2014-12-31 | Disclaimer |
| Accountancy firm name | 2014-12-31 | MCGLADREY LLP |
| Accountancy firm EIN | 2014-12-31 | 420714325 |
| 2013 : ASSOCIATED CLINICAL LABORATORIES RETIREMENT SAVINGS PLAN 2013 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2013-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2013-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2013-12-31 | $44,452 |
| Total income from all sources (including contributions) | 2013-12-31 | $4,942,665 |
| Total loss/gain on sale of assets | 2013-12-31 | $243,655 |
| Total of all expenses incurred | 2013-12-31 | $1,359,265 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2013-12-31 | $1,359,265 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2013-12-31 | $1,022,346 |
| Value of total assets at end of year | 2013-12-31 | $27,361,738 |
| Value of total assets at beginning of year | 2013-12-31 | $23,822,790 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2013-12-31 | $0 |
| Total interest from all sources | 2013-12-31 | $24,876 |
| Total dividends received (eg from common stock, registered investment company shares) | 2013-12-31 | $959,131 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2013-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2013-12-31 | $959,131 |
| Was this plan covered by a fidelity bond | 2013-12-31 | Yes |
| Value of fidelity bond cover | 2013-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2013-12-31 | No |
| Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2013-12-31 | $0 |
| Were there any nonexempt tranactions with any party-in-interest | 2013-12-31 | No |
| Contributions received from participants | 2013-12-31 | $702,168 |
| Participant contributions at end of year | 2013-12-31 | $679,434 |
| Participant contributions at beginning of year | 2013-12-31 | $555,494 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2013-12-31 | $64,145 |
| Other income not declared elsewhere | 2013-12-31 | $2,587 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2013-12-31 | No |
| Value of net income/loss | 2013-12-31 | $3,583,400 |
| Value of net assets at end of year (total assets less liabilities) | 2013-12-31 | $27,361,738 |
| Value of net assets at beginning of year (total assets less liabilities) | 2013-12-31 | $23,778,338 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2013-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2013-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2013-12-31 | No |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2013-12-31 | $20,086,675 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2013-12-31 | $16,971,565 |
| Interest on participant loans | 2013-12-31 | $24,876 |
| Value of interest in common/collective trusts at end of year | 2013-12-31 | $6,595,629 |
| Value of interest in common/collective trusts at beginning of year | 2013-12-31 | $5,947,814 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2013-12-31 | $2,639,307 |
| Net investment gain or loss from common/collective trusts | 2013-12-31 | $50,763 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2013-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2013-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2013-12-31 | No |
| Contributions received in cash from employer | 2013-12-31 | $256,033 |
| Employer contributions (assets) at beginning of year | 2013-12-31 | $347,917 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2013-12-31 | $1,359,265 |
| Liabilities. Value of benefit claims payable at beginning of year | 2013-12-31 | $44,452 |
| Did the plan have assets held for investment | 2013-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2013-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2013-12-31 | No |
| Aggregate proceeds on sale of assets | 2013-12-31 | $4,482,491 |
| Aggregate carrying amount (costs) on sale of assets | 2013-12-31 | $4,238,836 |
| Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2013-12-31 | Yes |
| Opinion of an independent qualified public accountant for this plan | 2013-12-31 | Disclaimer |
| Accountancy firm name | 2013-12-31 | MCGLADREY LLP |
| Accountancy firm EIN | 2013-12-31 | 420714325 |
